Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call Transcript
Source: SeekingAlpha
2025-10-07 12:48:57 ET
Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call
Company Participants
Chen Schor - CEO, President & Director
Julie Maltzman - Chief Medical Officer
Blake Aftab - Senior VP & Chief Scientific Officer ...
Read the full article on Seeking Alpha
For further details see:
Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call Transcript
Adicet Bio Inc.
NASDAQ: ACET
ACET Trading
2.79% G/L:
$7.37 Last:
106,860 Volume:
$6.98 Open:
ACET Latest News
ACET Stock Data
$70,641,246
7,595,730
46.88%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
